<DOC>
	<DOCNO>NCT00663481</DOCNO>
	<brief_summary>The purpose study determine safety tolerability CoFactor healthy subject .</brief_summary>
	<brief_title>A Clinical Trial CoFactor Formulations Leucovorin Administered Intravenously Healthy , Adult Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Tetrahydrofolates</mesh_term>
	<criteria>Males Females age 1865 inclusive screen . Subject agree practice abstinence medically accept contraception participate sperm donation vitro fertilization . Body Mass Index range 18 30 kg/m2 body weight 45 95 kg . Subject must healthy determine investigator basis screen evaluation . Subject must nonsmoker smoker few 10 cigarette per day determine history . Must able abstain smoking inclinic stay . Presence clinically significant illness within 21 day prior dose , viral bacterial infection , document drug allergy may affect subject 's safety study . Laboratory clinical evidence suggestive disease . Clinically significant predispose disorder may interfere absorption , distribution , metabolism and/or excretion drug . History drug abuse within 1 year dose and/or admit alcohol abuse history alcohol use may interfere ability comply . Pregnant , lactating , positive pregnancy test . Clinically significant electrocardiogram abnormality . History positive test hepatitis B C , HIV . Positive finding urine narcotic screen . History drug allergy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>CoFactor</keyword>
	<keyword>ANX-510</keyword>
</DOC>